4-hydroxy-25-desoxyneorollinicin has been researched along with myxothiazol in 1 studies
Studies (4-hydroxy-25-desoxyneorollinicin) | Trials (4-hydroxy-25-desoxyneorollinicin) | Recent Studies (post-2010) (4-hydroxy-25-desoxyneorollinicin) | Studies (myxothiazol) | Trials (myxothiazol) | Recent Studies (post-2010) (myxothiazol) |
---|---|---|---|---|---|
62 | 0 | 7 | 276 | 0 | 30 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bucchi, L; Carducci, C; Carelli, V; De Negri, A; Degli Esposti, M; Ghelli, A; Lenaz, G; Leuzzi, V; Lugaresi, E; Montagna, P | 1 |
1 other study(ies) available for 4-hydroxy-25-desoxyneorollinicin and myxothiazol
Article | Year |
---|---|
Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy.
Topics: Adult; Amino Acid Sequence; Blood Platelets; DNA, Mitochondrial; Female; Furans; Humans; Male; Methacrylates; Middle Aged; Molecular Sequence Data; Optic Atrophies, Hereditary; Pedigree; Point Mutation; Rotenone; Thiazoles | 1999 |